Insider · CIK 0001937412
Carladenise Armbrister Edwards
Files at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). First filing Mar 11, 2025, latest May 19, 2026.
Carladenise Armbrister Edwards files SEC Form 4 as director at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). Since Mar 11, 2025, Carladenise Armbrister Edwards has reported 0 open-market buys worth $0 and 2 open-market sells worth $952k, the latest filed on May 19, 2026.
A track record needs three past buys with six months of prices behind them; Carladenise Armbrister Edwards has 0, so none is measured yet.
The newest scored trade: sold $230k of CLOV on May 18, 2026, filed May 19, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $230k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLOV: CLOVER HEALTH INVESTMENTS, CORP. /DE
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | CLOVER HEALTH INVESTMENTS, CORP. /DE | $230k 67,160 shares | -19% | +99% from low-11% from high | |
| 61Notable | CLOVER HEALTH INVESTMENTS, CORP. /DE | $722k 200,000 shares | -42% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | 200,000 0.05% of outstanding | $744k | Mar 7, 2025 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SOpen-market sale Class A Common Stock | -67,160 | $3.42 | $230k | 285,432 | May 19, 2026 |
| Jan 6, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | AGrant or award Class A Common Stock | +79,365 | $0.00 | $0 | 352,592 | Jan 8, 2026 |
| Mar 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | SOpen-market sale Class A Common Stock | -200,000 | $3.61 | $722k | 273,227 | Mar 11, 2025 |
| Jan 6, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | AGrant or award Class A Common Stock | +60,975 | $0.00 | $0 | 473,227 | Jan 8, 2025 |
Questions about Carladenise Armbrister Edwards
Answered from the filings on this page, as of the latest one.
Is Carladenise Armbrister Edwards buying or selling?
In the last 12 months Carladenise Armbrister Edwards reported 0 open-market buys worth $0 and 1 open-market sell worth $230k on SEC Form 4; the latest was sold $230k of CLOV on May 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Carladenise Armbrister Edwards's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carladenise Armbrister Edwards has 0.
Where does Carladenise Armbrister Edwards file Form 4?
Carladenise Armbrister Edwards has filed Form 4 at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.